These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 105384)

  • 21. [Acute optical hallucinations in the juvenile neuronal ceroid lipofuscinosis (Spielmeyer-Vogt syndrome)].
    von Villiez T; Lagenstein I; Koepp P
    Acta Paedopsychiatr; 1981 May; 47(1):19-25. PubMed ID: 7020325
    [No Abstract]   [Full Text] [Related]  

  • 22. Feline GM 1 gangliosidosis: biochemical and ultrastructural comparisons with the disease in man.
    Farrell DF; Baker HJ; Herndon RM; Lindsey JR; McKhann GM
    J Neuropathol Exp Neurol; 1973 Jan; 32(1):1-18. PubMed ID: 4119597
    [No Abstract]   [Full Text] [Related]  

  • 23. Hexosaminidases and ganglioside catabolism in the GM2-gangliosidoses.
    Tallman JF
    Chem Phys Lipids; 1974 Dec; 13(4):292-304. PubMed ID: 4615840
    [No Abstract]   [Full Text] [Related]  

  • 24. Gangliosides, glycosidases, and sialidase in the brain and eyes of developing chickens.
    Schengrund CL; Rosenberg A
    Biochemistry; 1971 Jun; 10(12):2424-8. PubMed ID: 5115000
    [No Abstract]   [Full Text] [Related]  

  • 25. The lipidoses: morphologic changes in the nervous system in Gaucher's disease, GM2 gangliosidoses and Niemann-Pick disease.
    Arey JB
    Ann Clin Lab Sci; 1975; 5(6):475-88. PubMed ID: 812418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ceroid-lipofuscinosis (Batten disease). Fluorescein angiography, electrophysiology, histopathology, ultrastructure, and a review of amaurotic familial idiocy.
    Hittner HM; Ziller RS
    Arch Ophthalmol; 1975 Mar; 93(3):178-83. PubMed ID: 1138683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism of ovomucoid by the developing chick embryo.
    Oegema TR; Jourdian GW
    J Exp Zool; 1974 Aug; 189(2):147-62. PubMed ID: 4212161
    [No Abstract]   [Full Text] [Related]  

  • 28. Five gangliosidoses.
    O'Brien JS
    Lancet; 1969 Oct; 2(7624):805. PubMed ID: 4186052
    [No Abstract]   [Full Text] [Related]  

  • 29. Gangliosidoses.
    Svennerholm L
    Biochem J; 1969 Feb; 111(3):6P-8P. PubMed ID: 4975021
    [No Abstract]   [Full Text] [Related]  

  • 30. Tay-Sachs disease: interrelation of hexosaminidases A and B.
    Robinson D; Carroll M
    Lancet; 1972 Feb; 1(7745):322-3. PubMed ID: 4109961
    [No Abstract]   [Full Text] [Related]  

  • 31. Lipofuscin and ceroid pigments in aging and brain pathology. A review. I. Biochemical and morphological properties.
    Riga D; Riga S
    Rom J Neurol Psychiatry; 1995; 33(2):121-36. PubMed ID: 7547376
    [No Abstract]   [Full Text] [Related]  

  • 32. [Neuronal ceroid-lipofuscinoses].
    Neuhäuser G
    ZFA (Stuttgart); 1980 May; 56(13):923-6. PubMed ID: 6774499
    [No Abstract]   [Full Text] [Related]  

  • 33. Inactivation of GM1-ganglioside beta-galactosidase by a specific inhibitor: a model for ganglioside storage disease.
    Singer HS; Tiemeyer M; Slesinger PA; Sinnott ML
    Ann Neurol; 1987 May; 21(5):497-503. PubMed ID: 3035998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Partial deficiency of hexosaminidase component a in juvenile gm2-gangliosidosis.
    Suzuki Y; Suzuki K
    Neurology; 1970 Sep; 20(9):848-51. PubMed ID: 5466454
    [No Abstract]   [Full Text] [Related]  

  • 35. Further studies on the elucidation of the enzymatic defect in Tay-Sachs disease.
    Kolodny EH; Brady RO
    Neurology; 1970 Apr; 20(4):388. PubMed ID: 5535010
    [No Abstract]   [Full Text] [Related]  

  • 36. Ceramidase deficiency in Farber's disease (lipogranulomatosis).
    Sugita M; Dulaney JT; Moser HW
    Science; 1972 Dec; 178(4065):1100-2. PubMed ID: 4678225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of G M2 gangliosidosis of late onset.
    Buxton P; Cumings JN; Ellis RB; Lake BD; Mair WG; Roberts JR; Young EP
    J Neurol Neurosurg Psychiatry; 1972 Oct; 35(5):685-92. PubMed ID: 5084137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GM1 gangliosidosis type I.
    Weiss MJ; Krill AE; Dawson G; Hindman J; Cotlier E
    Am J Ophthalmol; 1973 Dec; 76(6):999-1004. PubMed ID: 4759862
    [No Abstract]   [Full Text] [Related]  

  • 39. Is neuronal ceroid lipofuscinosis a single disease entity?
    Pampiglione G; Harden A
    Trans Am Neurol Assoc; 1975; 100():227-9. PubMed ID: 1226622
    [No Abstract]   [Full Text] [Related]  

  • 40. Enzymatic aspects of sphingolipid degradation.
    Gatt S
    Chem Phys Lipids; 1970 Oct; 5(1):235-49. PubMed ID: 4920305
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.